Register Log-in Investor Type

News

05 Oct 2020

RTW Venture’s C4 Therapeutics IPO raises $182m

RTW Venture Fund (RTW), an investment company focused on identifying assets with high growth potential across the life sciences sector, noted the announcement by portfolio company, C4 Therapeutics, on 1 October of its pricing of a $182.4m IPO and admission to trading on the Nasdaq. ‘Robust pipeline in oncology’ C4T is a US‐based biotech company, described […]

30 Sep 2020

Portfolio and COVID-19 update from Standard Life Private Equity

Standard Life Private Equity (SLPE) has released an investment update covering the quarter to 30 June 2020. The NAV increased by 11.1% over the period (11.9% on a total return basis), taking into account valuations by all of SLPE’s external managers on the entire portfolio. £660.9m portfolio spread across 63 fund investments At the period-end, […]

30 Sep 2020

3i Infrastructure update – portfolio holding up well but lower power prices to affect valuations

In an update covering the period from 1 April to 29 September 2020, 3i Infrastructure (3IN) said that “most portfolio companies have met or exceeded the expectations we set at the start of the period, although lower power price forecasts, ongoing effects of the pandemic and the slow recovery in air travel will affect some […]

30 Sep 2020

Excellent year for tech-focused Manchester & London

The global sector company, Manchester and London (MNL), delivered a total NAV return of 12.8% over the full-year to 31 July 2020, which was over 30% ahead of its benchmark, the MSCI UK investable market index. Attribution – Microsoft, Alphabet, Facebook, Tencent, and Amazon all figure in the portfolio Information technology: +7.2% Communication services: +5.0% Consumer […]

30 Sep 2020

Early promise shown by some of India Capital Growth’s newer holdings

India Capital Growth (IGC) has reported interim results to 30 June 2020, with the NAV declining by 20.4% over the six months. The NAV increased by 22% from the low reached on 31 March and has continued to recover since the period-end, increasing by 14%, as at 31 August. Performance attribution – Aurobindo Pharma leads gains […]

30 Sep 2020

QuotedData’s morning briefing 30 September 2020

In QuotedData’s morning briefing 30 September 2020: The growth capital sector company, Schroder UK Public Private (SUPP), released interim results to 30 June 2020. The NAV declined by 8.1% (the decline since 1 April has been 1.5%). The following is an extract from the accompanying manager’s report: “Over this reporting period, the impact of the […]

28 Sep 2020

Africa Opportunity Fund makes realisation progress

Over Africa Opportunity Fund (AOF) interim results period to 30 June 2020, the NAV fell by (14%). Accounting for dividends and redemptions, the NAV decline was (7%). At the period end, equities accounted for 79% of the portfolio, debt took up 5% and unencumbered cash was responsible for the remaining 16%. As a reference, AOF […]

28 Sep 2020

Merian Chrysalis announces £50m placing and follow-on investment in leading European digital insurance platform

Merian Chrysalis (MERI) announced a proposed equity placing targeting £50m. The placing is priced at £1.48, which represents a premium to the estimated NAV per share of 142p, as at 30 June 2020. MERI also took the opportunity to announce a £15m follow-on investment in a convertible loan note of FinanceApp AG (wefox), which it […]

28 Sep 2020

ICG-Longbow Senior Secured UK Property Debt Investments displays resilience

The UK real estate debt investor ICG-Longbow Senior Secured UK Property Debt Investments (LBOW) has reported interim results for the six months to 31 July 2020. At the period-end, the NAV amounted to £119.2m, which compares with £119.1m as at 31 January 2020. Some of the key developments from the period include: No losses incurred or impairment […]

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…